Speaker: Bronwyn Marques, M.D. 

Title: Beyond the Luteal Phase: PMDD, Central Sensitization, and Clinical Complexity

Introduction:  Bronwyn Marques, M.D. is a PGY-4 psychiatry resident at Mayo Clinic, where she will graduate with an Area of Distinction in Reproductive and Sexual Health. She earned dual degrees in liberal arts and biochemistry from the University of Texas at Austin as a Forty Acres Scholar and went on to Stanford University School of Medicine. After residency, she will complete a Reproductive and Perinatal Psychiatry Fellowship at the University of Colorado.

Learning Objectives: 
Upon completion of this activity, participants should be able to:

• Describe the pathology mechanisms shared between PMDD and disorders of central sensitization, including HPA axis dysregulation, altered pain processing, and hormonal sensitivity.
• Differentiate the clinical profile of women with PMDD and comorbid central sensitization diagnosis from those with PMDD alone.
• Compare healthcare utilization patterns between women with PMDD with and without central sensitization comorbidity.

Speaker: Luca Hanvey

Title: Financial Toxicity and Cancer Quality of Life: Evaluating Relationships Among Hematopoietic Stem Cell Transplantation Recipients Through a Socioecological Model

Introduction:  Dr. Hanvey has dedicated the past seven years to their development as a scientist-practitioner in onco-psychology, specifically focused on dismantling cancer health inequities that disproportionately impact socially, economically, and medically marginalized populations in cancer care through their clinical and scientific pursuits. Their research investigates cancer health inequities through a socioecological perspective that adequately centers the upstream effects of interlocking forms of systemic marginalization, and in turn, social determinants of health, on the underserved in cancer care across quality of life, treatment, and survival outcomes. Overall, Dr. Hanvey’s work explores relationships among minoritized social identities, economic strain, and medical complexity in predicting various cancer outcomes, mechanisms that underpin these relationships, and future directions for achieving more equitable cancer care, as exemplified in their upcoming presentation. In their focus on the impacts of financial toxicity on various aspects of cancer-related quality of life, Dr. Hanvey addresses the critical importance of multifactorial social determinants of health to optimizing cancer care equity, as well as the necessity of comprehensive measurement to accurately evaluate such relationships.

Learning Objectives: 
Upon completion of this activity, participants should be able to:

1. Summarize intersectional impact of financial toxicity in hematologic cancers
2. Describe relationships between treatment cost burden and quality of life outcomes among bone marrow transplant recipients in a real-world dataset
3. Recognize necessity for future research that comprehensively conceptualizes and targets financial toxicity in its full socioecological context

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.